Home›Companies›Biotech & Pharma›Pacegenix

Pacegenix, Inc.

Develops treatments for people with heart rhythm disorders.

No LinkedIn page we could confirm. Why?
Updated Nov 10, 2026·Latest SEC filing Mar 26, 2026·Suggest an edit

About Pacegenix

Pacegenix is a private company based in Cambridge, Massachusetts, incorporated in 2024 in Delaware. It has reported $22,533,267 raised in one offering on Form D since March 2026. Its chief executive is Jay Wohlgemuth.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Mar 11, 2026Mar 26, 2026$22,533,267fully sold15$1.5MEquity, Debt, SAFE Convertible NotesRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Pacegenix's Form D filed Mar 26, 2026.

JW
Jay Wohlgemuth
CEO and director

Sources

  1. SECPacegenix, Inc. filing history
  2. CompanyPacegenix privacy policy